Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.45 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | UBE2N | P61088 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.38 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | HTR3A | P46098 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25753085 | 1.00 | THRB (0.45) | THRBNLRP3POLBUBE2NTP53 | |
| SCHEMBL23950845 | 0.85 | THRB (0.43) | THRBNLRP3POLBUBE2NTP53 | |
| SCHEMBL25754628 | 0.74 | NLRP3 (0.50) | THRBNLRP3POLBUBE2NTP53 | |
| SCHEMBL25753044 | 0.74 | THRB (0.47) | THRBNLRP3POLBUBE2NTP53 | |
| SCHEMBL23950819 | 0.74 | THRB (0.48) | THRBNLRP3POLBUBE2NTP53 | |
| SCHEMBL25753079 | 0.73 | NLRP3 (0.45) | THRBNLRP3POLBUBE2NTP53 | |
| SCHEMBL23950187 | 0.73 | POLB (0.46) | THRBNLRP3POLBUBE2NKMT2A | |
| SCHEMBL23950404 | 0.71 | NLRP3 (0.54) | THRBNLRP3POLBUBE2NKMT2A | |
| SCHEMBL23950419 | 0.71 | THRB (0.45) | THRBNLRP3POLBUBE2NTP53 | |
| SCHEMBL25753019 | 0.71 | KMT2A (0.69) | POLBUBE2NTP53KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021209552-A1 | PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY | JANSSEN PHARMACEUTICA NV (BE) | 2021-10-21 | — | — | WO | disclosed |